{"id":"W4410803166","doi":"10.1200/jco.2025.43.16_suppl.tps10074","title":"A phase 1/2, open-label study evaluating the efficacy, safety, and pharmacokinetics of luveltamab tazevibulin in infants and children &lt; 12 years of age with <i>CBFA2T3::GLIS2</i> acute myeloid leukemia.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacokinetics; Open label; Oncology; Internal medicine; Adverse effect","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000836767,0.001375519,0.001790801,0.0003019854,0.0003202186,0.001001886,0.0007574929,0.001049042,0.00447307],"category_scores_gemma":[0.0007940358,0.0006072214,0.001010199,0.0003275478,0.0007922873,0.0009757455,0.0003183663,0.003391014,0.001198055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001220295,"about_ca_system_score_gemma":0.001644477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001095718,"about_ca_topic_score_gemma":0.002876637,"domain_scores_codex":[0.9997086,0.0001006981,0.00001171104,0.00006787926,0.00004003391,0.00007113944],"domain_scores_gemma":[0.999464,0.00007085448,0.0001168817,0.00004199126,0.00004046263,0.000265852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6017864,0.1338672,0.01059025,0.001740052,0.002127892,0.001035614,0.0005758356,0.003265288,0.08923899,0.0008024644,0.01319731,0.1417726],"study_design_scores_gemma":[0.3855776,0.5801293,0.01438871,0.00007907253,0.0006725586,0.001182515,0.0001806098,0.001932828,0.006254184,0.0003969839,0.009147853,0.0000577337],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887482,0.002424895,0.001006706,0.0004792709,0.0001470904,0.002849569,0.002518989,0.0001646775,0.001660594],"genre_scores_gemma":[0.9805543,0.003044923,0.002519271,0.001191351,0.0001311177,0.004413281,0.004356963,0.0000827495,0.003705872],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00447307,"threshold_uncertainty_score":0.01496387,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1107606440725963,"score_gpt":0.5383015413904161,"score_spread":0.4275408973178197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}